Transurethral resection of the prostate combined with 2-micron continuous-wave laser vaporesection for benign prostatic hyperplasia with the prostate volume > 80 ml.
- Author:
Xiao-lei REN
;
Zhi-ming GAO
;
Hai-bo XIA
;
Guo-chang BAO
;
Chun-sheng LI
;
Hao ZHANG
- Publication Type:Journal Article
- MeSH: Aged; Blood Loss, Surgical; Humans; Laser Therapy; methods; Male; Middle Aged; Organ Size; Prostate; pathology; Prostatic Hyperplasia; pathology; surgery; Quality of Life; Retrospective Studies; Transurethral Resection of Prostate; methods; Treatment Outcome; Urethral Stricture; Urinary Incontinence; etiology; Urinary Retention
- From: National Journal of Andrology 2015;21(2):136-139
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo sum up the clinical experience in the management of benign prostatic hyperplasia (BPH) with the prostate weighing over 80 ml by transurethral resection of the prostate (TURP) combined with 2 μm continuous-wave laser vaporesection (LVR).
METHODSWe retrospectively analyzed the clinical effects of TURP combined with 2 μm LVR in the treatment of 46 cases of BPH with the prostate volume > 80 ml.
RESULTSAll the operations were successfully accomplished. The operation time and intraoperative blood loss were (112.0 ± 20.0) min (range 86-176 min) and (77.9 ± 25.9) ml (range 50-200 ml), respectively. The catheters were withdrawn at 7 days after surgery. Transient urinary incontinence occurred in 6 cases and secondary hemorrhage was found in 2 postoperatively. Six-month follow-up revealed no urethral stricture or other complications. Compared with the baseline, the international prostate symptom score (IPSS) was significantly decreased at 6 months after operation (26.3 ± 1.8 vs 11.6 ± 1.7, P <0.05), and so were the quality of life (QOL) score (5.3 ± 0.7 vs 1.3 ± 1.1, P <0.05) and post-void residual urine (PVR) ([115.5 ± 55.6] ml vs [19.9 ± 11.6] ml, P <0.05). However, the maximum urinary flow rate (Qmax) was remarkably increased from (4.1 ± 2.6) ml/s to (16.2 ± 1.7) ml/s (P <0.05).
CONCLUSIONTURP combined with 2 μm LVR is safe and effective for the treatment of BPH with the prostate volume >80 ml.